Intravaginal gels as drug delivery systems

Journal of Women's Health
Mary Justin-TemuGuy Van Den Mooter

Abstract

Recently, there has been a great deal of interest in the design and application of different dosage forms via the vaginal route. Several studies have proven that the vagina is an effective route for drug administration intended mainly for local action, but systemic effects of some drugs also can be attained. The major advantages of this route include accessibility, good blood supply, the ability to bypass first-pass liver metabolism, and permeability to large molecular weight drugs, such as peptides and proteins. Among the delivery systems proposed for this route is the use of intravaginal gels, which have been found to be potential vaginal drug delivery systems. The bioadhesives used in the formulation of gels play a key role in the release of the drug through the attachment to the vaginal mucosa, where the drug diffuses from the gel to the mucus.

References

Dec 1, 1978·British Journal of Obstetrics and Gynaecology·P D Wilson
Feb 1, 1977·Journal of Pharmaceutical Sciences·E OwadaG L Flynn
Jan 1, 1990·Scandinavian Journal of Infectious Diseases·E Holst, A Brandberg
Mar 1, 1990·Human & Experimental Toxicology·J M Sanders, H B Matthews
Jul 1, 1985·Oral Surgery, Oral Medicine, and Oral Pathology·S J Pimlott, M Addy
Jan 1, 1994·Journal of Perinatal Medicine·K T SchneiderW Rath
Feb 1, 1996·Acta Obstetricia Et Gynecologica Scandinavica·M Nuutila, P Kajanoja
Aug 1, 1996·Biomaterials·N A Peppas, J J Sahlin
Oct 1, 1996·Geburtshilfe und Frauenheilkunde·W Rath, W Heyl
May 1, 1997·American Journal of Obstetrics and Gynecology·E L EasonL Joseph
May 1, 1997·Human Reproduction·C BullettiF Franceschetti
Dec 16, 1997·Obstetrics and Gynecology·S J CarlanW F O'Brien
Mar 12, 1998·Contraception·C J EliasA M Salvatierra
Apr 3, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M K StaffordV S Kitchen
Oct 17, 1998·Sexually Transmitted Diseases·D L PattonS L Hillier
Apr 1, 1999·Sexually Transmitted Diseases·N GagnéM G Bergeron
May 20, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·H SjöbergN Caram-Lelham
Jun 17, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·D H OwenD F Katz
Sep 4, 1999·Journal of Clinical Pharmacy and Therapeutics·S J TaylorC L Armour
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·N A PeppasA M Lowman
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·N A PeppasH Ichikawa
Jan 31, 2003·AIDS·Kenneth H MayerUNKNOWN HIV Prevention Trials Network (HPTN) 020 Protocol Team

❮ Previous
Next ❯

Citations

Sep 16, 2010·Pharmaceutical Research·Alamelu MahalingamPatrick F Kiser
Jan 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Samuel K LaiJustin Hanes
Jul 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·David P WilsonSally M Blower
Aug 20, 2011·Drug Development and Industrial Pharmacy·Valence M K NdesendoLeith C R Meyer
Sep 27, 2012·Drug Development and Industrial Pharmacy·Samata MehtaChris Vervaet
Feb 22, 2013·Journal of Non-Newtonian Fluid Mechanics·Savas TasogluAndrew J Szeri
Jun 17, 2015·Menopause : the Journal of the North American Menopause Society·Salvatore CarusoAntonio Cianci
Jan 13, 2009·Advanced Drug Delivery Reviews·Yen Cu, W Mark Saltzman
Mar 26, 2016·Journal of Pharmaceutical Sciences·Angela M JarrettDavid F Katz
Jun 24, 2006·Peptides·Crispin R Dass, Peter F M Choong
Apr 20, 2006·International Journal of Pharmaceutics·J das Neves, M F Bahia
Oct 18, 2005·International Journal of Pharmaceutics·Armorél D van Eyk, Pieter van der Bijl
Apr 30, 2015·Pharmaceutical Development and Technology·Noorullah Naqvi MohammedMichael A Repka
Apr 16, 2015·Drug Delivery and Translational Research·Y GaoD F Katz
Dec 3, 2014·International Journal of Pharmaceutics·Maria Campaña-SeoaneFrancisco J Otero-Espinar
May 1, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·A B KimballR Langer
May 26, 2017·Clinical Microbiology Reviews·Kawthar BouchemalPhilippe M Loiseau
Aug 6, 2019·Advanced Pharmaceutical Bulletin·Unnati GargNeha Jain
Mar 29, 2016·The Journal of Pharmacy and Pharmacology·Natascia MenniniPaola Mura
Sep 29, 2011·Alternatives to Laboratory Animals : ATLA·Gertrude-Emilia CostinRoger D Curren
Aug 31, 2017·Scientific Reports·Reham F El-KasedM M Elmazar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Alamdar Hussain, Fakhrul Ahsan
Fertility and Sterility
Nancy J AlexanderEdio Zampaglione
The AAPS Journal
Lisa C Rohan, Alexandra B Sassi
Contraception
Derek H Owen, David F Katz
© 2021 Meta ULC. All rights reserved